Clinical trial

Observational Study on Safety and Efficacy of Biphasic Insulin Aspart in Type 2 Diabetes Patients

NCT00834262

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2009-04-01

PhaseN/A

Study timeline

Study start (unknown)2009-04-01Date precision: month

Registry last updated2016-10-31

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetesunresolved

Diabetes Mellitus, Type 2unresolved

Interventions

biphasic insulin aspart 30DRUG

biphasic insulin aspart 50DRUG

biphasic insulin aspart 70DRUG

Sponsors & collaborators

Novo Nordisk A/Slead sponsor

Mapped research locations

Kfar SabaIsrael1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00834262 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.